BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12357124)

  • 1. Appetite suppressants and valvular heart disease.
    Seghatol FF; Rigolin VH
    Curr Opin Cardiol; 2002 Sep; 17(5):486-92. PubMed ID: 12357124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
    JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL
    JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valvular heart disease associated with fenfluramine-phentermine.
    Connolly HM; Crary JL; McGoon MD; Hensrud DD; Edwards BS; Edwards WD; Schaff HV
    N Engl J Med; 1997 Aug; 337(9):581-8. PubMed ID: 9271479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

  • 9. Appetite-suppressing drugs and valvular heart disease.
    Cannistra LB; Gaasch WH
    Cardiol Rev; 1999; 7(6):356-61. PubMed ID: 11208248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operation for anorexigen-associated valvular heart disease.
    Caccitolo JA; Connolly HM; Rubenson DS; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):656-64. PubMed ID: 11581595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart valve disorders and appetite-suppressant drugs.
    Jick H
    JAMA; 2000 Apr; 283(13):1738-40. PubMed ID: 10755501
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity drugs and the heart.
    Connolly HM; McGoon MD
    Curr Probl Cardiol; 1999 Dec; 24(12):745-92. PubMed ID: 10609092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.
    Pallasch TJ
    J Calif Dent Assoc; 1999 May; 27(5):400-4. PubMed ID: 10528558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
    Wee CC; Phillips RS; Aurigemma G; Erban S; Kriegel G; Riley M; Douglas PS
    Ann Intern Med; 1998 Dec; 129(11 Pt 1):870-4. PubMed ID: 9867728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
    Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
    N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe heart valve disease on appetite suppressants.
    Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
    [No Abstract]   [Full Text] [Related]  

  • 19. Appetite suppressants and valvular heart disease.
    Weissman NJ
    Am J Med Sci; 2001 Apr; 321(4):285-91. PubMed ID: 11307869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appetite suppressants and valvular heart disease - a systematic review.
    Loke YK; Derry S; Pritchard-Copley A
    BMC Clin Pharmacol; 2002 Aug; 2():6. PubMed ID: 12194699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.